With serum sodium 104 mmol/L, this requires immediate hospital/ICU-level management. Treat as chronic or unknown-duration hyponatremia unless a clearly acute onset is proven.
Immediate treatment
If severe symptoms are present
Seizure, coma, marked confusion, vomiting, respiratory distress, or signs of raised intracranial pressure:
- Give 3% hypertonic saline IV bolus:
- 100 mL over 10 minutes, repeat up to two further times if severe symptoms persist, or
- 150 mL over 20 minutes, reassess, and repeat as needed.
- Initial aim: raise serum sodium by 4-6 mmol/L to relieve cerebral edema and neurologic danger, not to normalize the sodium immediately.
This needs frequent serum sodium measurement, usually every
1-2 hours during active correction. A current review describes the guideline-supported bolus approach and an initial 4-6 mmol/L rise as the target for symptomatic disease (
management review).
Prevent overcorrection
Because Na is 104, the patient is at very high risk for osmotic demyelination syndrome if sodium rises too fast.
- Aim for no more than 6-8 mmol/L rise in the first 24 hours.
- Avoid more than 16-18 mmol/L over 48 hours.
- Use the more conservative ≤8 mmol/L per 24 h limit, especially if malnutrition, alcoholism, hypokalemia, liver disease, or very low sodium is present.
- Check urine output closely. Sudden water diuresis can cause a dangerous rapid rise in sodium.
If correction is becoming too rapid:
- Stop hypertonic saline.
- Give desmopressin (DDAVP) to stop water diuresis.
- Give 5% dextrose (D5W) to relower or slow the sodium rise, under specialist supervision.
Patients receiving hypertonic saline need sodium and volume-status checks every 1-4 hours during active therapy.
Brenner and Rector's The Kidney, monitoring serum sodium section. A systematic review also confirms the serious risk of osmotic demyelination with excessive correction (
PMID 37523718).
After initial stabilization: likely SIADH treatment
Given the earlier pattern, if SIADH is confirmed:
-
Stop the trigger, if present
Review drugs such as thiazides, SSRIs, carbamazepine, antipsychotics, opioids, cyclophosphamide, vincristine, and recent hypotonic IV fluids. Investigate pulmonary disease, CNS disease, pain/nausea, malignancy, and postoperative causes.
-
Fluid restriction
Usually 800-1,000 mL/day, individualized to urine electrolytes and clinical state.
-
Do not give routine 0.9% saline for SIADH
With concentrated urine and high urine sodium, normal saline may fail to correct sodium or can worsen hyponatremia.
-
If persistent despite fluid restriction, specialist options include:
- Oral urea
- Loop diuretic plus oral sodium chloride, in selected patients
- Tolvaptan, only with specialist oversight and careful sodium monitoring because rapid correction can occur. Recent reviews support urea and low-dose tolvaptan as possible SIADH therapies, but neither replaces emergency hypertonic-saline management (urea review, PMID 39362395; tolvaptan review, PMID 40288608).
Also urgently check glucose, potassium, creatinine, cortisol/ACTH evaluation, TSH/free T4, medication history, volume status, and neurologic symptoms. Adrenal insufficiency must be excluded before labeling this SIADH.